Enhabit, Inc. (NYSE:EHAB) Short Interest Down 5.4% in January

Enhabit, Inc. (NYSE:EHABGet Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 1,220,000 shares, a decline of 5.4% from the December 31st total of 1,290,000 shares. Based on an average daily trading volume, of 375,300 shares, the short-interest ratio is presently 3.3 days. Approximately 2.8% of the company’s shares are sold short.

Analysts Set New Price Targets

EHAB has been the subject of a number of research analyst reports. Leerink Partners reissued a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and lifted their price target for the stock from $8.25 to $9.50 in a research note on Monday, December 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Enhabit presently has a consensus rating of “Hold” and a consensus price target of $8.75.

View Our Latest Stock Analysis on Enhabit

Enhabit Price Performance

Shares of NYSE:EHAB opened at $8.46 on Tuesday. The company has a 50-day moving average price of $8.00 and a 200 day moving average price of $8.04. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The company has a market cap of $425.12 million, a P/E ratio of -3.64 and a beta of 1.83. Enhabit has a 52 week low of $6.85 and a 52 week high of $11.74.

Enhabit (NYSE:EHABGet Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same quarter in the previous year, the business posted $0.03 EPS. Research analysts predict that Enhabit will post 0.22 earnings per share for the current year.

Insider Activity

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of Enhabit stock in a transaction dated Tuesday, December 10th. The stock was purchased at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the purchase, the director now directly owns 46,810 shares of the company’s stock, valued at $412,396.10. The trade was a 47.15 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Jeffrey Bolton purchased 4,000 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was acquired at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the completion of the transaction, the director now directly owns 98,144 shares of the company’s stock, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.90% of the company’s stock.

Institutional Trading of Enhabit

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC boosted its holdings in shares of Enhabit by 514.3% during the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock worth $7,119,000 after buying an additional 754,395 shares during the period. Marshall Wace LLP acquired a new stake in Enhabit in the second quarter worth $1,941,000. Paradice Investment Management LLC grew its position in shares of Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock valued at $13,903,000 after purchasing an additional 201,997 shares during the period. Systematic Financial Management LP lifted its position in shares of Enhabit by 12.2% in the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock worth $14,522,000 after purchasing an additional 199,235 shares in the last quarter. Finally, Bardin Hill Management Partners LP raised its stake in shares of Enhabit by 927.4% during the 3rd quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock worth $1,377,000 after purchasing an additional 157,338 shares in the last quarter.

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

See Also

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.